The role of radiotherapy for stages I and II

Strahlentherapie und Onkologie

Volumn 186, Issue 4, 2010, Pages 191-196

  Heinzelmann, F ^a   Engelhard, Marianne ^b   Ottinger, Hellmut ^b   Bamberg, Michael ^a   Weinmann, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Dose; Early stages; External beam radiotherapy; Follicular lymphoma; Target volume

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLICULAR LYMPHOMA; HUMAN; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIATION FIELD; RADIATION SICKNESS; REVIEW; TREATMENT FAILURE; METHODOLOGY; MORTALITY; PATHOLOGY; RADIOTHERAPY; RISK FACTOR; TUMOR RECURRENCE; WHOLE BODY RADIATION;

DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC IRRADIATION; LYMPHOMA, FOLLICULAR; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RISK FACTORS; WHOLE-BODY IRRADIATION;

EID: 77951651776     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2090-9     Document Type: Review

References (60)

1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780-2795
2. Besa PC, McLaughlin PW, Cox JD, et al. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer 1995;75:2361-2367
3. Carde P, Burgers JM, van Glabbeke M, et al. Combined radiotherapy- chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 1984;2:301-312
4. Denham JW, Denham E, Dear KB, et al. The follicular non-Hodgkin's lymphomas - I. The possibility of cure. Eur J Cancer 1996;32A:470-479
5. Eich HT, Heimann M, Stutzer H, et al. Long-term outcome and prognostic factors in early-stage nodal low-grade non-Hodgkin's lymphomas treated with radiation therapy. Strahlenther Onkol 2009;185:288-295
6. Eich HT, Muller RP. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma. Strahlenther Onkol 2007;183:16-18
7. Eich HT, Muller RP, Engenhart-Cabillic R, et al. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 2008;184: 406-410
8. Epelbaum R, Kuten A, Coachman NM, et al. Stage I-II low grade non-Hodgkin's lymphoma: prognostic factors and treatment results. Strahlenther Onkol 1992;168:66-72.
9. Fuks Z, Kaplan HS. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 1973;108:675-684
10. Glatstein E, Fuks Z, Goffinet DR, et al. Non-Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 1976;37:2806-2812
11. Gospodarowicz MK, Bush RS, Brown TC, et al. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 1984;10:489-497
12. Gospodarowicz MK, Lippuner T, Pintilie M, et al. Stage I and II follicular lymphoma: longterm outcome and pattern of failure following treatment with involved field radiation therapy alone. Int J Radiat Oncol Biol Phys 1999;45 (Suppl):217:abstract 137.
13. Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 2005;37:409-419
14. Guadagnolo BA, Li S, Neuberg D, et al. Long-term outcome and mortality trends in early-stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006;64:928-934
15. Ha CS, Cabanillas F, Lee MS, et al. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report. Clin Cancer Res 1997;3:215-219
16. Ha CS, Cabanillas F, Lee MS, et al. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Int J Radiat Oncol Biol Phys 2005;63: 188-193
17. Ha CS, Kong JS, McLaughlin P, et al. Stage III follicular lymphoma: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 2003;57:748-754
18. Harris NL, Jaffe ES, Die bo Id J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849
19. Herold M, Haas A, Srock S, et al. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lym- phoma: an East German Study Group Hematology and Oncology Study. J Clin Oncol 2007;25:1986-1992
20. Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005;106:3725-3732
21. Jacobs JP, Murray KJ, Schultz CJ, et al. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. J Clin Oncol 1993;11:233-238
22. Kamath SS, Marcus RB Jr, Lynch JW, et al. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1999;44:563-568
23. Kaminski MS, Tuck M, Estes J, et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 2005;352:441-449 (Pubitemid 40175970)
24. Kelsey SM, Newland AC, Hudson GV, et al. A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkin's lymphoma. Med Oncol 1994;11:19-25.
25. Ladetto M, Drandi D, Compagno M, et al. PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003;21:1398-1403
26. Landberg TG, Hakansson LG, Moller TR, et al. CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas: preliminary results of a randomized study. Cancer 1979;44:831-838
27. Lopez-Guillermo A, Cabanillas F, McLaughlin P, et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood 1998;91:2955-2960
28. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282-1290
29. Marcus R, Imrie K, Belch A, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005;105:1417-1423
30. McLaughlin P, Fuller LM, Velasquez WS, et al. Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer 1986;58:1596-1602
31. Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980;6:125-134
32. Murtha AD, Rupnow BA, Hansosn J, et al. Long-term follow-up of patients with stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001;49:3-15. (Pubitemid 32041272)
33. Neumann H, Blanek H, Koch R, et al. [Follicle centre lymphoma: treatment results for stage I and IL] Strahlenther Onkol 2003;179:840-846
34. Nissen NI, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1983;52:1-7.
35. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918
36. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002;99:3806-3812
37. Ott OJ, Rodel C, Gramatzki M, et al. Radiotherapy for stage I-III nodal Low-grade non-Hodgkin's Lymphoma. Strahlenther OnkoL 2003;179:694-701.
38. Paryani SB, Hoppe RT, Cox RS, et al. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer 1983;52:2300-2307
39. Paryani SB, Hoppe RT, Cox RS, et al. The role of radiation therapy in the management of stage III foLLicuLar Lymphomas. J CLin Oncol 1984;2:841-848
40. Pendlebury S, el Awadi M, Ashley S, et al. Radiotherapy results in early stage Low grade nodal non-Hodgkin's Lymphoma. Radiother Oncol 1995;36: 167-171
41. Petersen PM, Gospodarowicz M, Tsang R, et al. Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol 2004;22:Suppl 14:abstract 6521.
42. Press OW, Unger JM, Braziel RM, et al. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine 1-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911. J Clin Oncol 2006;24:4143-4149
43. Pulsoni A, Starza ID, Frattarelli N, et al. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy. Br J Haematol 2007;137:216-220
44. Richaud PM, Soubeyran P, Eghbali H, et al. Place of Low-dose total body irradiation in the treatment of Localized follicular non-Hodgkin's lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 1998;40:387-390
45. Rochet N, Sterzing F, Jensen A, et al. Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 2008;184:145-149 (Pubitemid 351365782)
46. Salles G, Mounier N, de Guibert S, et al. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood 2008;112:4824-4831
47. Seymour JF, Pro B, Fuller LM, et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol 2003;21:2115-2122 (Pubitemid 46606360)
48. Specht L. Primary radiotherapy of localised indolent non-Hodgkin's lymphoma. Radiother Oncol 2002;64(Suppl 1):abstract 7a.
49. Sterzing F, Schubert K, Sroka-Perez G, et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008;184:8-14.
50. Studer G, Luetolf UM, Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol 2007;183:417-23, discussion 424-425 (Pubitemid 47230517)
51. Stuschke M, Hoederath A, Sack H, et al. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien. Cancer 1997;80:2273-2284 (Pubitemid 28007399)
52. Sutcliffe SB, Gospodarowicz MK, Bush RS, et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985;4:211-223 (Pubitemid 16225435)
53. Tsang RW, Gospodarowicz MK. Low-grade non-Hodgkin lymphomas. Semin Radiat Oncol 2007;17:198-205.
54. Tsang RW, Gospodarowicz MK. Non-Hodgkin's lymphoma. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. Philadelphia: Elsevier Churchill Livingstone, 2007:1713-1751
55. Tsang RW, Gospodarowicz MK, O'Sullivan B. Staging and management of Localized non-Hodgkin's lymphomas: variations among experts in radiation oncology. Int J Radiat Oncol Biol Phys 2002;52:643-651 (Pubitemid 34158725)
56. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994;69:1088-1093 (Pubitemid 24161865)
57. Voordeckers M, Everaert H, Tournel K, et al. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer. Strahlenther Onkol 2008;184:400-405
58. Voss NJS, Klasa RJ, Fairey RN. The treatment of early stage, Low grade non-Hodgkin's lymphoma with involved-field region irradiation. The BCCA experience. Ann Hematol 2001;80(Suppl 3):abstract B153.
59. Wilder RB, Jones D, Tucker SL, et al. Long-term results with radiotherapy for stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001;51:1219-1227 (Pubitemid 33116314)
60. Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer 1993;71:2342-2350